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The severely attenuated and host range (HR) restricted modified vaccinia virus Ankara (MVA) was derived by >500
passages in chick embryo fibroblasts, during which multiple deletions and mutations occurred. To determine the basis of the
HR defect, we prepared cosmids from the parental vaccinia virus Ankara genome and transfected them into nonpermissive
monkey BS-C-1 cells that had been infected with MVA. Recombinant viruses that formed macroscopic plaques were detected
after transfections with DNA segments that mapped near the left end of the viral genome. Plaque-forming viruses, generated
by transfections with four individual cosmids and one pair of minimally overlapping cosmids, were purified, and their HRs
were evaluated in BS-C-l cells, rabbit RK-13 cells, and human Hela, MRC-5, and A549 cells. The acquisition of the K1land
SPI-l HR genes and the repair of large deletions were determined by polymerase chain reaction or pulse-field gel
electrophoresis of Notf restriction enzyme digests of genomic DNA. The following results indicated the presence of
previously unrecognized vaccinia virus HR genes: (1) the major mutations that restrict HR are within the left end of the MVA
genome because the phenotypes of some recombinants approached that of the parental virus, (2) acquisition of the K1l gene
correlated with the apility of recombinant viruses to propagate in RK-13 cells but did not enhance replication in human or
monkey cell lines. (3) acquisition of the SPI-1 gene correlated with virus propagation in A549 cells but not with the extent of
virus spread in monkey or other human cell lines, (4) there are at least two impaired HR genes because rescue occurred with
nonoverlapping or minimally overlapping cosmids and recombinant viruses with intermediate HRs were isolated, and (5) at
least one of the new HR genes did not map within any of the major deletions because the size of the left terminal Notl
fragment was not appreciably altered in some recombinant viruses.
INTRODUCTION
Modified vaccinia virus Ankara (MVA) was developed
as a safe smallpox vaccine by >500 passages in primary
chick embryo fibroblasts (CEF), after which it could no
longer replicate or replicated very poorly in a variety of
mammalian cell lines and was nonpathogenic even for
immunodeficient animals (Hochstein-Mintzel et el., 1972;
Mayr et el., 1975. 1978). Moreover, no serious complica-
tions were reported when the MVA smallpox vaccine was
administered to >100,000 people (Mahnel and Mayr,
1994; Stickl et et; 1974). After the eradication of smallpox,
renewed interest in MVA stemmed from the finding that it
might have use as a safe and efficient expression vector
(Sutter and Moss, 1992; Sutter et al., 1995; Wyatt et et.,
1995) and recombinant vaccine to prevent other infec-
tious diseases (Bender et et., 1996; Durbin et el., 1998;
Hanke et et., 1998; Hirsch et al., 1996; Seth et al., 1998;
Sutter et al., 1994; Wyatt et et., 1996) and cancer (Carroll
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et et., 1997). Indeed, in several instances, MVA appeared
to be as or more effective than a replication-competent
vaccinia virus vaccine vector (Belyakov et el., 1998; Car-
roll et aI., 1997; Hirsch et aI., 1996; Schneider et et., 1998;
Sutter et al., 1994), possibly because of deletion of host
immune evasion genes (Antoine et aI., 1998; Blanchard et
et., 1998).
Although no host range (HR) revertants of MVA have
ever been reported, a better understanding of the basis
of the replication defect is needed to evaluate its safety
as a vector. The HR restriction of MVA is unique in
several respects. First, efficient replication has been
described only in primary CEFs and Syrian hamster
BHK-21 cells (Carroll and Moss, 1997; Drexler et et.,
1998). Second, the block in most nonpermissive cells
occurs at a late stage of the MVA replication cycle:
during virion morphogenesis. In contrast, viral protein
synthesis is inhibited soon after nonpermissive infec-
tions with orthopoxviruses that have mutations in most
other HR genes, and in some cases the infected cells
undergo apoptosis (Brooks et el., 1995; Chang et el.,
1995; Gillard et et., 1985; Ink et el., 1995; Njayou et el.,
1982; Ramsey-Ewing and Moss, 1995,1996). The genetic
basis of the MVA HR restriction is, therefore, of basic as
well as practical interest
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Isolation and characterization of HR-extended
recombinant viruses
Virus present in large plaques derived from at least
two independent transfections of BS-C-1 cells with each
cosmid or with a pair of cosmids were repeatedly
plaque-purified to separate them from the parental MVA.
The abilities of these recombinant viruses to replicate
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FIG. 1. Map locations of vaccinia virus DNA segments of cosmids
that provided marker rescue. The positions of cos51, cos44, cos4?, and
cos16 are shown above a map indicating Hindlll restriction endonu-
clease sites in the MVA genome. The asterisks indicate the locations of
seven major deletions. The inverted terminal repetition (ITR) and
unique Notl restriction endonuclease site are shown by arrows. The
terminal portions of cos51 and cos44 are within the ITR and therefore
also are present on the right end of the genome.
convenience, we started with an existing cosmid library
(Thompson and Condit, 1986) derived from the WR strain
of vaccinia virus, which replicates well in BS-C-1 and
human cells. Surprisingly, no plaque-forming recombi-
nant viruses were detected. We considered that this
failure might be due to strain-specific gene rearrange-
ments interfering with recombination or defects in the
WR cosmid library and therefore prepared new cosmids
containing DNA from the parental Ankara strain of vac-
cinia virus. When they were used for transfection, four
cosmids designated cos16, cos44, cos47, and cos51 con-
sistently rescued viruses with increased plaque size.
Recombinant viruses rescued by cos44 or cos51 pro-
duced 0.25- to 0.33-mm-diameter plaques in 48 h,
whereas those rescued by cos47 or cos16 produced
0.12- to 0.20-mm-diameter plaques. Under these condi-
tions, the Ankara strain produced plaques of >1 mm,
whereas MVA produced microscopic size foci of <0.1
mm.
The vector-viral DNA junctions of cos16, cos44, cos47,
and cos51 were sequenced to accurately determine the
region of the DNA that provided marker rescue. Signifi-
cantly, all four mapped to the left end of the genome, with
cos44 extensively overlapping with cos51 and cos16
largely overlapping with cos47 (Fig. t), However, not all
of the cosmids overlapped with each other, indicating
that there must be at least two HR genes. In further
support of this, viruses forming plaques of 0.5-1.0 mm in
48 h were obtained when cos51 or cos44 were cotrans-
fected with cos47 or cos16.
Marker rescue of the MVA HR defect
In view of the long passage history of MVA and evi-
dence for extensive deletions, it seemed likely that the
HR defect might be due to mutations in multiple genes,
which would make marker rescue difficult. To improve
our chance of success, we used cosmids containing
large viral DNA fragments for recombination and BS-C-1
cells, in which MVA replication was severely but not
completely inhibited, as the host. Previous studies had
indicated that MVA produced small microscopic foci of
two to five infected BS-C-1 cells by 24 h, increasing to
~20 infected cells by 72 h (Carroll and Moss, 1997). For
RESULTS
At least five orthopoxvirus HR genes have been de-
scribed: Chinese hamster ovary (CHO)hr (Gillard et el.,
1985), C7L (Oguiura et et., 1993; Perkus et et., 1990), K1 L
(Perkus et aI., 1990), E3L (Beattie et et., 1996; Chang et
aI., 1995), and SPI-1 (Ali et al., 1994). The homolog of the
cowpox virus CHOhr gene is disrupted or deleted in all
analyzed strains of vaccinia virus, and restoration of an
intact gene is required for replication in CHO cells. Ex-
pression of either CHOhr, K1 L, or C7L allows vaccinia
virus replication in human MRC-5 and pig kidney PK-15
cells. and either K1 L or CHOhr permits replication in
rabbit kidney RK-13 cells (Perkus et aI., 1990). The E3L
gene is required for vaccinia virus replication in monkey
VERO and human HeLa cells (Beattie et al., 1996; Chang
et al., 1995), and the SPI-1 gene is required for replication
of rabbitpox virus in PK-15 or human A549 cells (Ali et al.,
1994). With the exception of the E3L gene, which codes
for a double-stranded RNA binding protein (Chang et et.,
t992), the functions of the HR genes are unknown.
Restriction endonuclease analysis indicated six major
deletions at the two ends of the MVA genome, compos-
ing ~15% of the parental DNA (Altenberger et al., 1989;
Meyer et al., 1991). This result was recently confirmed
and extended to show additional mutations by determi-
nation of the complete genomic sequence of MVA (An-
toine et el., 1998). K1 Land SPI-1 are the only known
vaccinia virus HR genes that are deleted from MVA.
Replacement of the K1 L gene and flanking sequences
extended the HR of MVA to RK-13 cells (Meyer et el.,
1991) but not to other tested mammalian cell lines (Car-
roll and Moss, 1997). Because the phenotype of MVA
could not be explained by the loss of known orthopoxvi-
rus HR genes, we undertook a marker rescue approach
to locate the apparently unknown ones. Here, we de-
scribe the construction of cosmids containing the
genomic DNA of the parental Ankara strain, the marker
rescue experiments, and the characterization of HR ex-
tended recombinant viruses. The results indicate that the
HR defect of MVA is due to mutations or small deletions
of multiple genes located near the left end of the ge-
nome.
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and spread in monkey (BS-C-1), rabbit (RK-13), hamster
(CHO), and human (Hel.a. MRC-5, and A549) cells were
compared with the abilities of Ankara, MVA, and an MVA
recombinant with a repaired K1 L gene (MVNK1 L). The
foci or plaques formed by recombinant viruses were
visualized after 48 h by immunostaining. Photographs of
foci or plaques obtained with one set of recombinant
viruses in most of the cell lines are shown in Fig. 2, and
the relative sizes of these and others obtained by inde-
pendently derived recombinant viruses in additional cell
lines are summarized in Table 1. The largest plaques
were formed by Ankara, and the smallest foci were
formed by MVA. MVNK1 L formed small foci in RK-13 cells
but otherwise was still replication deficient. In contrast,
the plaques formed by recombinant viruses 44/47.1 and
44/47.2, generated by cotransfection with cos44 and
cos47, were only slightly smaller than those formed by
Ankara in each of the cell lines tested. Recombinant
viruses 51.1 and 51.2, generated by transfection with
cos51, had an extended HR but produced plaques that
were smaller than those of the 44/47 recombinant vi-
ruses. One cos51 recombinant, 51.1, could also form foci
in RK-13 cells (Fig. 2), whereas another, 51.2, could not
(Table 1), suggesting that different amounts of vaccinia
virus Ankara DNA had recombined with MVA DNA in the
two independent isolates. Recombinant viruses formed
with cos44 were very similar to those generated by
cos51 as expected from the extensive overlap of the DNA
sequences (Fig. 1); 44.1 did not replicate in RK-13 cells
(Fig. 2), whereas 44.2 did (Table 1). The recombinant
viruses formed with cos47 spread better than MVA in
BS-C-1 cells but did not exhibit enhanced replication in
any of the other cell lines (Fig. 2, Table 1). Virus spread
in A549 cells followed a pattern that was similar to that in
HeLa and MRC-5 cells (Table 1). Neither the Ankara
strain of vaccinia virus nor any of the MVA recombinants
were' able to spread in CHO cells, consistent with a
nonfunctional CHOhr gene in all cases.
To evaluate HR in a more quantitative fashion, repli-
cate monolayers of BS-C-1, MRC-5, HeLa, and RK-13
cells were infected with each of the viruses at a multi-
plicity of infection (m.o.i.) of 0.01. The low multiplicity was
chosen so that both replication and virus spread would
be measured. After 48 h, the cells and medium were
harvested together and the numbers of infectious parti-
cles were determined on CEF. The yields of Ankara were
3-5 logs higher than those of MVA, depending on the cell
line (Table 2). Moreover, the yields obtained for 44/47.1,
44/47.2, 51.1, and 44.2 were very similar to those of An-
kara in all cell lines (Table 2). The yields of 51.2 and 44.1
also were similar to Ankara, except for the low values in
RK-13 cells (Table 2). In contrast, 47.1 and 47.2 replicated
well only in BS-C-1 cells, and MVNK1 L replicated signif-
icantly only in RK-13 cells. These data were consistent
with the results obtained microscopically (Fig. 2, Table 1).
By 48 h, the 44/47, 51, and 44 recombinant viruses had
infected the entire monolayers, probably accounting for
the similar amounts of virus formed in each case, even
though the plaque size analysis (Fig. 2) had indicated
different rates of virus spread.
Integration of the K1 Land SPI-1 genes correlated
with replication in RK-13 cells and A549 cells,
respectively
An initial PCR analysis (not shown) demonstrated that
the K1 L gene was present in cos51 and cos44 DNA,
which accounted for their ability to rescue the RK-13 cell
HR defect of MVA. However, some recombinant viruses
generated with these cosmids acquired the ability to
replicate in BS-C-1, MRC-5, and HeLa cells but not in
RK-13 cells (Fig. 2, Tables 1 and 2). These data sug-
gested the presence of HR genes unlinked to K1 L in
cos51 and cos44. To confirm this interpretation, we per-
formed a PCR analysis to determine the presence of the
K1L gene in the DNA of the recombinant viruses. A PCR
fragment of ~3000 bp was expected when the K1 L gene
and flanking sequences were present, and a fragment of
-325 bp was expected when the K1 L gene was unre-
paired. Full-length K1 L DNA was found in Ankara, 44/47.1,
44/47.2, 51.1, 44.2, and MVNK1 L (Fig. 3). In contrast, K1 L
DNA was absent from MVA, 51.2,44.1,47.1, and 472 (Fig.
3). Thus there was a perfect correlation between acqui-
sition of the complete K1L gene and replication in RK-13
cells.
PCR analysis demonstrated that the SPI-1 g~ne was
present in cos44 (Fig. 4) and therefore should also be
present in cos51, although this was not directly tested.
The SPI-1 gene was found in the genomes of Ankara,
44/47.1, 44/47.2, 51.1, 51.2, 44.1, and 44.2 (Fig. 4). However.
SPI-1 DNA was not detected in the genomes of MVA,
MVNK1 L, and 47.1 (Fig. 4). Thus there was a correlation
between acquisition of SPI-1 and virus spread in A549
cells (Table 1). However, the SPI-1 gene was not the
main determinant of virus propagation in any of the cell
lines tested because recombinant viruses that acquired
the SPI-1 gene varied considerably in this ability (e.g.,
compare 44/47 with 44 in Tables 1 and 2).
Pulse-field DNA analyses of recombinant viruses
Together, the four cosmids that enhance replication of
MVA make up >80,000 bp of vaccinia virus DNA (Fig. 1).
Earlier studies (Meyer et aI., 1991), confirmed by the
recent complete genome sequence of MVA (Antoine et
al., 1998), revealed large deletions within the left and
right terminal regions. Several of these deletions map
within cos51 and cos44 and are to the left of a unique
Notl site (Fig. 1). To determine whether the recombina-
tiona I events that extended the HR of MVA resulted from
the replacement of all or the majority of this deleted DNA,
the sizes of the Notl genome fragments were compared
by pulse-field gel electrophoresis (Fig. 5). The left termi-
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FIG. 2. Cell-to-cell virus spread. Monolayers of the indicated cells (BS-C-1, MRC-5. Hel.a, or RK-13l were infected with MVA, Ankara, MVNK1 L, or
recombinant viruses formed by marker rescue with cos44 and cos47 (44/47) or individual cosmids. The decimal number signifies recombinant viruses
obtained from independent transfections. After 48 h. the cells were fixed and immunostained with anti-vaccinia virus antibody followed by horseradish
peroxidase conjugated to anti-rabbit immunoglobulin.
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TABLE 1
Plaque Analysis of Ankara/MVA Recombinants
Cells
Virus BS-C-1 MRC-5 HeLa A-549 RK-13
Ankara ++++8 +++++ +++ ++++ ++++
44/47.1 +++ +++++ ++ ++++ ++++
44/47.2 +++ +++++ ++ ++++ +++
51.1 ++ ++++ + ++ ++
51.2 ++ ++++ + ++ 0
44.1 ++ ++++ + + 0
44.2 ++ ++++ + ++ +++
47.1 ++ + 0 0 0
47.2 + + 0 NDb 0
MVAIKIL + + 0 0 +
MVA + + 0 0 0
"Relative plaque or focus size produced compared with other vi-
ruses. + + + + + denotes the largest diameter plaques/foci and +
denotes the smallest after fiXing the cells and immunostaining with
anti-vaccinia rabbit serum followed by anti-rabbit horseradish peroxi-
dase as described under Materials and Methods.
b Not done.
nal Notl fragment of Ankara is ~50,000 bp, whereas the
corresponding fragment of MVA is 37,000 bp. The size of
the Notl fragment of recombinant virus 51.1 was similar to
that of Ankara, indicating a near-total replacement of the
DNA deleted from the left end of the MVA genome. The
size of the left terminal Notl fragment of 44/47.1 was only
slightly smaller, indicating extensive repair of the dele-
tions. Most interesting, however, was the finding that the
Notl fragment of recombinant 44.1 was similar in size to
that of MVA and smaller than that of MVNK1L. Because
major deletions in cos44 map within the left terminal Notl
fragment, it means that at least one HR gene is not
associated with any of the major deletions.
TABLE 2
Replication of Ankara/MVA Recombinants in Various Cell Lines
Cells
Virus BS-C-1 MRC-5 HeLa RK-13
Ankara 6.8" 6.4 6.8 7.1
44/47.1 7.2 7.0 7.2 7.6
44/47.2 7.4 7.2 6.9 7.8
51.1 7.7 7.1 6.7 7.6
51.2 6.7 6.8 6.6 3.3
44.1 7.1 5.6 6.4 3.2
44.2 7.9 6.1 6.6 7.1
47.1 7.1 4.4 4.3 3.0
47.2 6.4 4.2 4.6 3.6
MVAIKIL 4.8 3.0 39 6.1
MVA 4.2 2.6 3.2 2.0
Note. Virus infection was at an rn.o.i, at 0.01, harvested at 48 h.
a 10glO'
3000 bp-.
220 bp-.
FIG. 3. PCRanalysis of K1 L gene. peR was performed using primers
that flanked the MVA deletion of the K1 L gene and DNA from CEF
infected with the indicated viruses. A photograph of an ethidium bro-
mide stained agarose gel is shown. Arrows point to the positions of the
3000- and 220-bp DNA markers. MWM indicates molecular weight
markers.
DISCUSSION
Our finding that repair of multiple genes is required to
fully restore the ability of MVA to replicate efficiently in
human cells is consistent with the inability to detect
spontaneous revertants and supports the safety of MVA
as a vaccine vector. The phenotype of MVA is unlike that
of any other vaccinia virus HR mutant with regard to its
spectrum of permissive and nonpermissive cell lines and
to the stage of replication that is blocked. We were
particularly interested in the human cell restriction, both
for practical reasons related to the use of MVA as a
vaccine vector and because the defect cannot be ex-
plained by the previously identified HR genes of vaccinia
virus. The most significant results of the present study
are summarized as follows: (1) marker transfer experi-
ments demonstrated thatthe major HR mutations of MVA
are within the left side of the genome, (2) MVA has at
least two nonfunctional HR genes in addition to K1 L
because rescue occurred with nonoverlapping or mini-
mally overlapping cosmids and recombinant viruses with
intermediate HR phenotypes were isolated, (3) at least
one of the putative new HR genes did not map within any
of the major deletions because the size of the left termi-
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FIG. 4. PCR analysis of SPI-1 gene. peR was performed using
primers within the SPI-1 gene and DNA obtained as described in the
legend to Fig. 3. A photograph of an ethidium bromide-stained agarose
gel is shown. Arrows point to the positions of the 396-bp DNA markers.
MWM indicates molecular weight markers.
VACCINIA VIRUS HOST RANGE GENES 339
...J
e ~ :ii:
'"
r..: ~ <
""
..,. ~
c: ~ ~ <i > >< ..,. ..,. :E :E
50 kbp....
FIG. 5. Pulse-field gel electrophoresis of Noll-d igested vaccinia virus
DNA. Total DNA from cells infected with vaccinia virus Ankara, MVA,
MVNK1 L, 44/47.1, 51.1, or 44.t was embedded in agarose, digested with
Noti, and resolved by pulse-field gel electrophoresis. The gel was
stained wi th ethidium bromide and photographed. The position of a
50-kbp A DNA marker is shown by the arrow. The bands similar in size
or smaller than the marker represent the left Noti fragments (Fig. 1).
The intense bands that migrate more slowly than the marker represent
the right Not l fragments as well as any undigested DNA that would not
be resolved under these conditions.
nal Notl fragment of one recombinant virus was not
grossl y altered from that of MVA, and (4) one or more HR
genes mutated in MVA do not correspond to any previ-
ously recognized with HR function in vacc inia virus. Be-
cause the plaque sizes in human cells of the rescued
MVA viruses approached but did not fully equal those of
the parental Ankara strain , additional genes possibly
located in the central or right ends of the genome could
provide an additive effect. In th is respect, we did not
cotransfect all possible combinations of cosmids, and
our library was incomplete near the right end of the
genome compared with Copenhagen strain sequences.
Although the present work was largely completed
with out knowledge of the genome sequence of MVA, we
had the opportunity to interpret our results in light of the
recently publ ished data (Antoine et al., 1998). Relative to
the Copenhagen strain of vaccin ia virus, the left terminal
region of the MVA genome contains four large delet ions
as well as many fragmented open reading frames, leav-
ing only eight structurally intact. The open reading
frames in the central region of the MVA genome are
largely intact with the except ion of three (F5l, F11 l, and
01 l). Because F5l and F11 l should be present in cos44
and 01 l should be in cos47, they are candidate HR
genes. However, Antoi ne et st. (1998) cited their unpub-
lished experiments indicating that these three genes are
nonessen tial for vaccinia virus stra in WR, making their
role in HR less likely. Other genes in the central regio n
contai n small in-frame delet ions or insertions or point
mutations that may alter function. The right te rminal
region contains three large deleti ons as well as many
disruptions of open reading frames.
Of the three known vaccini a virus HR genes, C7l and
E3l are intact in MVA, whereas K1l is partially deleted
(Antoine et al., 1998). Restoration of the K1 l gene, how-
ever, did not restore replication competence to MVA fo r
eithermonkey or human cells, indicating that at least two
other vaccinia virus HR genes exist. One candidate was
the SPI-1 gene, whi ch is absent from MVA (Antoine et et.,
1998) and is required for replication of rabbitpo x virus in
pig kidney PK-15 and human A549 cells (Ali et al., 1994).
Recent studies (J. Shisler and B. Moss , unpublished
observations) indicated that the SPI-1 gene also is re-
quired for replication of vaccinia virus strain WR in A549
cells. Using PCR, we determined that the SPI-1 gene is
present in the genome of the Ankara strain of vaccin ia
virus and in all of the MVA recombinants that could
spread in A549 cells . However, the size of the foci or
plaques in the BS-C-1 and human cell lines did not
correlat e with the acquisition of the SPI-1 gene. There-
fore, the absence of the SPI-1 gene may contribute to the
HR defect in A549 cells, but it is not a determining factor
for replication in most cell lines .
The CHOhr gene, which is intact in cowpox virus but
interrupted in MVA (Antoine et al., 1998) and interrupted
or absent in other strains of vaccin ia virus (Goebel et al.,
1990; Kotwal and Moss, 1988), was not cons idered to be
a factor in the marker rescue experiments because nei-
ther vaccinia virus strain Ankara nor any of the MVA
recombinants could replicate in CHO cells. In addition,
PCR experiments indicated that the CHOhr gene is not
intact in cos44 (unpublished data).
One difficulty in deducing the mutated HR genes from
the MVA sequence data (Antoine et el., 1998) is the
unavailab il ity of the sequence of the corresponding pa-
rental Ankara strain. Compar ison of the MVA sequence
with the published sequence of the vaccinia virus
Copenhagen strain (Goebel et al., 1990) could be prob-
lematic because the ends of orthopoxvirus genomes
undergo frequent transpositions and deletions (Archard
et al., 1984; Esposito et al., 1981). For example, the SPI-1
gene is located near the left end of the Copenhagen
strain of vacc inia virus (Goebel et al.. 1990) but near the
right end of the WR stra in (Kotwal and Moss, 1989; Smith
et et., 1989). In view of the many genes present in the
terminal regions of low passage isolates of cowpox virus
(Shchelkunov et al., 1998) and the long indep endent
passage histories of vaccinia virus strains, it is possible
that Ankar a contains some orthopoxvirus genes not
present in the Copenhagen or WR strai ns of vaccinia
virus that account for rescue. Such additiona l genes
could explain our success in achieving marker rescue
with Ankara cosm ids but not w ith a WR cosmid library.
There are, however, more likely explanations for the
inability to rescue with the WR cosmid library, including
mutat ions, deletions, or rearrangements in the latter rel-
ative to Ankara.
Our plans for the future include sequencing the left
side of the Ankara genome, constitut ing the relevant
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portions of cos51, 44, 47, and 16. By comparing this
sequence with that of MVA, we hope to identify candidate
HR genes and test them individually and in combination
by marker rescue methods.
MATERIALS AND METHODS
Cells and viruses
CEF were prepared from 9-day-old embryos and used
in the first passage for virus infections. BS-C-1 [American
Type Culture Collection (ATCC) CCl 26). MRC-5 (ATCC
CCl 171), RK-13 (ATCC CCl 37), Hela (ATCC CCl 2.2),
and A549 (ATCC CCl 185; a gift of J. Shisler) cells were
propagated in EMEM (Quality Biologicals) supplemented
with 10% fetal bovine serum. Plaque-purified MVA, the
parental Ankara strain provided by G. Sutter, MVNK1 L
with a functional K1 l gene (Meyer et al., 1991), and the
Ankara/MVA recombinants were all propagated in CEF
except where noted in the text. Virus titers were deter-
mined by immunostaining in CEF as described (Carroll
and Moss, 1997).
Preparation of cosmids containing vaccinia virus
Ankara DNA
Vaccinia virus Ankara was plaque-purified in B8-C-1
cells, grown in Hela 83 cells, and purified by sucrose
gradient sedimentation (Earl et al., 1991). The purified
virus was digested with proteinase K, and full-length viral
genome DNA was isolated after ethanol precipitation
(Earl et aI., 1991). The DNA was partially digested with
Sau3A to obtain fragments of ~40 kbp and ligated to
BamHI-digested Super Cos1 vector (Stratagene). The
Stratagene "gigapack" phage extract was used for pack-
aging the DNA, and Xl-1 Blue Escherichia coli was
infected. The bacteria were plated onto agar-containing
ampicillin, and colonies were screened by hybridization
to DNA probes derived from the entire vaccinia virus
Ankara genome. DNA prepared from positive colonies
was digested with Hindlll to identify the region of the
Ankara genome using maps that had been previously
published (Meyer et et., 1991). The junctions of the viral
DNA and vector of selected cosmids were determined by
sequencing.
Marker rescue and isolation of recombinant MVA
Subconfluent monolayers of BS-C-1 cells in six-well
dishes were infected with MVA at an m.o.i. of 0.1 and
transfected with 2-3 /-Lg of cosmid using Lipofectin
(GIBCO BRl) or DOTAP (Boehringer-Mannheim) accord-
ing to protocols provided by the manufacturers. After
48 h, the cells were harvested, lysed by freezing and
thawing three times, and sonicated. The Iysates were
diluted and used to infect replicate fresh BS-C-1 cell
monolayers. After 2 days, both crystal violet-fixed and
unfixed monolayers were examined for plaques. The
largest plaques were picked and plaque-purified three
times, and a small stock was made of each for further
analysis.
Replication of the recombinant viruses in various cell
lines
For analysis of plaque formation, confluent monolay-
ers in Costar six-well tissue culture dishes were infected
with serial dilutions of 10-10,000 plaque-forming units
(pfu) in 1 ml of medium containing 2% FBS.After 48 h, the
monolayers were immunostained with vaccinia virus-
specific polyclonal rabbit sera and either protein A or
anti-rabbit Ig conjugated to horseradish peroxidase (Car-
roll and Moss, 1997).
For analysis of virus replication, confluent monolayers
in Costar six-well plates were infected at an m.o.i. of
~0.01 using a total of 1 X 104 pfu in 1 ml of medium
containing 2% FBS. After 1 h at 3rC, the cells were
washed once with medium containing 2% FBS and incu-
bated with fresh medium at 3rc The cells and super-
natant were harvested at 48 h after absorption After
freeze thawing thrice and brief sonication, samples were
assayed in duplicate on monolayers of CEF. Infected cell
foci were visualized after 24 h by immunostaining (Car-
roll and Moss, 1997).
PCR analysis
Monolayers of CEF were infected with 10 pfu of virus
per cell. After 20 h, the cells were harvested, and DNA
was obtained using the QIAamp Blood Kit (Qiagen) ac-
cording to the manufacturer's directions. Sequences
flanking the region containing the Kil deletion were
amplified by PCR using the primers 5'-GGTICATIGT-
TATCCATIGCAGAGGACG-3' and 5'-CGTGCGTCTAGTAT-
GTACGTIGTIG-3' to determine the presence or absence
of Kil DNA. The primers 5'-ACCCACCATCATATCAA-
CACTGG-3' and 5'-CACCCGATGACAATAATGACATGG-3'
were used in PCR to derive a 379-bp product from the
internal portion of the SPI-1 gene.
Analysis of DNA by pulse-field gel electrophoresis
Monolayers of CEF were infected with 1 pfu of MVA
per cell. After 24 h, the cells were harvested and resus-
pended in cell suspension buffer (BioRad Genomic DNA
Plug Kit) at 107 cells/ml. An equal volume of 2%CleanCut
agarose (BioRad) pre incubated at 50°C was added, and
the cell suspension was formed into 100-/-LI plugs. After
solidification at 4°C, the plugs were treated with protein-
ase K as previously described (Merchlinsky and Moss,
1989). The plugs were equilibrated with Notl restriction
enzyme digestion buffer, digested with Notl, and sub-
jected to electrophoresis on a BioRad CHEF DRII appa-
ratus for 22 h at 6 V/cm with a switching time of 2 s. The
agarose gel was stained with ethidium bromide and
photographed.
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